Impact of the Food Matrix on Iodine Bioavailability

NCT ID: NCT04867031

Last Updated: 2023-01-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

13 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-08-26

Study Completion Date

2018-07-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a randomized crossover trial, lasting 12 days in total, which will assess the difference in iodine bioavailability (as a percentage of iodine consumed that is excreted in urine) from three iodine-rich foods; semi-skimmed milk, white fish, and dried seaweed sheets. Each of the three foods will provide approximately 140µg of iodine, and iodine excretion will be monitored for 36 hours following food ingestion via collection and analysis of urine.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Iodine insufficiency is one of the three key micronutrient deficiencies highlighted as major public health issues by the World Health Organisation, and recent evidence indicates that the UK is now iodine deficient. Iodine deficiency represents a particular threat for women of child-bearing age, unborn infants and young children, as iodine is essential to synthesise the thyroid hormones, which are involved in key metabolic function including fetal brain development. Maternal iodine deficiency and the resulting changes in thyroid function has been associated with adverse pregnancy outcomes including spontaneous miscarriage, fetal distress and death, preterm delivery, low birth weight and impaired neuropsychological development, with significant impact on later life development and quality of life.

There is no iodine fortification programme in the United Kingdom, and despite worldwide efforts to tackle iodine deficiency and associated disorders via iodine supplementation and food-fortification (of salt mainly), consumption of supplements in the UK is virtually non-existent, with iodised salt used by less than 5%.

In the UK, the main dietary sources of iodine are dairy and sea-foods. Our previous studies have shown that seaweed intake can increase the iodine status of women with diets habitually low in iodine. Reduced bioavailability of iodine from the seaweed matrix, which could have implications for dietary recommendations.

This study address the influence of the food matrix on iodine bioavailability, in the context of food guidelines and assessment of the iodine status.

This project is in collaboration with the British Broadcast Corporation (BBC).

The study design is a crossover randomised trial - to last 9 days, plus three days pre-trial washout \[total 12 days\] - with 3 arms:

1. fish arm: portion equivalent to 140 µg iodine, approx. 130g.
2. milk arm: portion equivalent to 140 µg iodine, approx. 450mL.
3. seaweed arm: portion equivalent to 140 µg iodine, approx. 6g.

Each arm will be separated by two washout days, and participants will follow a low iodine diet (avoiding dairy, and all seafood) throughout the study, as well as three days prior to the first arm. Iodine levels will be monitored in urine collected during the 12 hours preceding and 36 hours following the meal. Urine will be collected in time fractions

A parallel design study showed that 56% (SD 20%) of a dose of potassium iodide is excreted after 24hours, compared to 36% (SD 13%) when the same dose comes from seaweed. In order to detect a similar difference, a sample of at least 13 participants is required (n=19 to allow for 30% attrition).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Iodine Bioavailability

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

White fish (cod)

Participants will consume 1 portion (\~130g) of white fish (Bird's Eye Inspirations Cod Fillets with Tomato \& Rosemary), providing approximately 140µg of iodine, alongside 452mL of water. Urine will be collected for 36 hours following test food consumption.

Group Type EXPERIMENTAL

Fish

Intervention Type DIETARY_SUPPLEMENT

One portion of cod (approx. 130g), providing \~140µg of iodine.

Semi-skimmed milk

Participants will consume 1 portion (\~450mL) of milk (Tesco UHT Semi-Skimmed), providing approximately 140µg of iodine, alongside 452mL of water. Urine will be collected for 36 hours following test food consumption.

Group Type EXPERIMENTAL

Milk

Intervention Type DIETARY_SUPPLEMENT

One portion of semi-skimmed cow's milk (approx. 450mL), providing \~140µg of iodine.

Dried seaweed sheets

Participants will consume 1 portion (\~6g) of dried seaweed sheets (Itsu Crispy Seaweed Thins), providing approximately 140µg of iodine, alongside 452mL of water. Urine will be collected for 36 hours following test food consumption.

Group Type EXPERIMENTAL

Seaweed

Intervention Type DIETARY_SUPPLEMENT

One portion of dried seaweed sheets (approx. 6g), providing \~140µg of iodine.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Milk

One portion of semi-skimmed cow's milk (approx. 450mL), providing \~140µg of iodine.

Intervention Type DIETARY_SUPPLEMENT

Fish

One portion of cod (approx. 130g), providing \~140µg of iodine.

Intervention Type DIETARY_SUPPLEMENT

Seaweed

One portion of dried seaweed sheets (approx. 6g), providing \~140µg of iodine.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy
* Male or female
* Aged 18-48
* Signed informed consent

Exclusion Criteria

* Pregnancy and lactation
* Past and present thyroid conditions
* Diseases of the gastrointestinal tract
* Allergy to seafood or dairy
* Consumption of iodine supplements
* Currently taking medication (other than the contraceptive pill)
* Having a habitual diet very low in iodine (\<1 portion of dairy per day, or \< 1 portion of fish per week)
Minimum Eligible Age

18 Years

Maximum Eligible Age

48 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

British Broadcasting Corporation

INDUSTRY

Sponsor Role collaborator

University of Glasgow

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Emilie Combet

Senior Lecturer in Nutrition

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Emilie Combet, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Glasgow

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Section of Human Nutrition, University of Glasgow

Glasgow, North Lanarkshire, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

200160161

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Brown Seaweed as a Breast Cancer Preventive
NCT01204957 COMPLETED PHASE1/PHASE2
Soy and Isoflavones Effect on Bone
NCT00668447 COMPLETED PHASE4